Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : IPT001
Therapeutic Area : Oncology
Study Phase : IND Enabling
Sponsor : European Innovation Council
Deal Size : $6.4 million
Deal Type : Financing
Details : The financing will enable InProTher to advance its lead drug candidate, IPT001, a first-in-class immunotherapy against solid tumors, into clinical development.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
May 24, 2023
Lead Product(s) : IPT001
Therapeutic Area : Oncology
Highest Development Status : IND Enabling
Sponsor : European Innovation Council
Deal Size : $6.4 million
Deal Type : Financing